-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design
Panagiotis A Konstantinopoulos , Ursula A Matulonis
Clinical Trail Methodology: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation
-
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia
Brad Spellberg, Roger J Lewis, Helen W Boucher,Eric P Brass
Review Article: Clinical Investigation